Head Cancer
Summary of lecture on Head and Neck Cancer at HMRI ENT update 2023
Delayed presentation
Due to COVID
Smoking and alcohol are risk factors, these patients tend to minimize symptoms
Mortality
Increasing 5-year survival rate as some cancer are very treatable
Incidence increasing 3% per year, especially younger patients
More HPV virus induced cancers
Stats
5000 in Aus diagnosed yearly
1900 Oral
700 Lip
1300 Pharynx
600 Laryngeal
200 Nasal
Risk factors
Smoking, tobacco, cigars, vapes
ETOH
HPV
Beetel nut
Erythroplakia
Por dental hygiene
Immunosuppression
Sun
obesity
family history
Pharyngeal
Nasopharynx
Nasopharyngeal carcinoma
Asian descent, more endemic
EBV related commonly
Oropharyngeal
Common
Tonsil and back of the tongue
HPV
Expecting reducing in burden due to vaccine soon
HPV
16 and 18
Affected tumour suppression genes
More common in smokers still
Oral cancers mostly
Larygneal Cancer
Reducing in incidence due to less smoking
Constant persistent change in voice
Concerns
Unilateral pain on swallow, referred to ear
Haemoptysis
Oral Cancer
Persisting buccal or oral lesion
20 to 40-year-old non-smokers often present with an SCC
Persisting and growing = bad, needs biopsy
Aggressive tumours, not sure why
Thyroid lumps
Single node
Most are benign
More concerning in kids or if family history
Is there compression?
Is the patient toxic?
Papillary, follicular, medullary
Multiple nodes
Goitre
Large goitre often benign
Occasionally aggressive tumour
Needs cytology
Lateral nodes
Voice change
Thyrotoxic
ACR TI-RADS system = start with Ultrasound, FNA
Post-treatment HN cancer
Regular TFT
Post XRT should have Carotid U/S 2 years and 4 years post
Lymphodema PT
XRT increases risk of Thyroid Cancer